Jefferies Financial Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45,000
Closed -$4.29M 1774
2025
Q4
$4.29M Buy
+45,000
New +$4.41M 0.02% 535
2025
Q1
Sell
-101,100
Closed -$9.03M 1649
2024
Q4
$9.03M Sell
101,100
-198,800
-66% -$17.5M 0.05% 246
2024
Q3
$25.1M Buy
+299,900
New +$23.6M 0.18% 72
2023
Q2
Sell
-10,000
Closed -$500K 1694
2023
Q1
$500K Sell
10,000
-52,500
-84% -$2.47M ﹤0.01% 1090
2022
Q4
$2.89M Buy
+62,500
New +$2.71M 0.02% 536

Other funds holding BSX

Jefferies Financial Group's BSX Position: Q1 2026 in Review

Jefferies Financial Group reduced its Boston Scientific (BSX) stake by 95% in Q1 2026, selling an estimated $20.4M and leaving 14,014 shares worth $879K. The position accounts for 0.01% of the portfolio, ranked #978.

Jefferies Financial Group first reported a position in BSX in Q2 2018 and has held it in 15 quarters since. The position peaked at $66.3M in Q2 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Jefferies Financial Group held 14,014 shares of Boston Scientific worth $879K as of Q1 2026.
  • Jefferies Financial Group sold 254,806 Boston Scientific shares in Q1 2026, an estimated $20.4M.
  • Boston Scientific made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #978 holding.
  • Jefferies Financial Group first reported a position in Boston Scientific in Q2 2018 and has held it in 15 quarters since.
  • Jefferies Financial Group's Boston Scientific position peaked at $66.3M in Q2 2024.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.